Vanguard Fiduciary Trust
ARCT icon

Vanguard Fiduciary Trust’s Arcturus Therapeutics ARCT Stock Holding History

Vanguard Fiduciary Trust’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17M Buy
174,048
+4,236
+2% +$33.4K ﹤0.01% 2962
2026
Q1 		$1.31M Buy
+169,812
New +$1.24M ﹤0.01% 2787

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Fiduciary Trust's ARCT Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Arcturus Therapeutics (ARCT) stake by 2.5% in Q2 2026, buying an estimated $33.4K and bringing the position to 174,048 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2962.

Vanguard Fiduciary Trust first reported a position in ARCT in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.31M in Q1 2026. 133 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Vanguard Fiduciary Trust held 174,048 shares of Arcturus Therapeutics worth $1.17M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 4,236 Arcturus Therapeutics shares in Q2 2026, an estimated $33.4K.
  • Arcturus Therapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2962 holding.
  • Vanguard Fiduciary Trust first reported a position in Arcturus Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Arcturus Therapeutics position peaked at $1.31M in Q1 2026.
  • 133 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.